130
Participants
Start Date
December 9, 2011
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Blood Tests
If participant received retroviral gene therapy, blood test performed to check for a type of infection called the replication-competent retrovirus (RCR). Blood (up to 4 tablespoons each time) drawn every 3 months for first year after gene transfer therapy and once a year after that.
Questionnaires
"Once a year during Years 1-5, questionnaire completions that asks about medical history (general health, the status of any medical conditions, and any illnesses or hospitalizations that may have occurred). It should take about 15-30 minutes to complete.~Once a year during Years 6-15, completion of mailed questionnaire. Participant will be asked about medical history (including if participant has had any children since the infusion) and whether there have been any changes in contact information. The questionnaires should take about 15-30 minutes each time."
RECRUITING
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
National Center for Research Resources (NCRR)
NIH
National Cancer Institute (NCI)
NIH
Alaunos Therapeutics
INDUSTRY
M.D. Anderson Cancer Center
OTHER